Circulating tumor DNA tumor fraction as a biomarker in refractory metastatic colorectal cancer: findings from the CAVE-2 GOIM trial

The Journal of Liquid Biopsy · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles